Compounds > didimethylsulfoxide-dichloroplatinum(ii)

didimethylsulfoxide-dichloroplatinum(ii) and Adenocarcinoma

didimethylsulfoxide-dichloroplatinum(ii) has been researched along with Adenocarcinoma* in 1 studies

Other Studies

1 other study(ies) available for didimethylsulfoxide-dichloroplatinum(ii) and Adenocarcinoma

Article	Year
Hypercoagulopathy induced by chemotherapy in a patient with lung cancer. A possible role for a factor with thrombosis-inducing activity (TIA). Chest, 1992, Volume: 101, Issue:1 We treated a patient with lung cancer in whom a hypercoagulopathy was induced acutely by chemotherapy. He received systemic chemotherapy twice and in both instances developed disseminated intravascular coagulopathy (DIC), accompanied by acute decrements of the peripheral platelet count and plasma fibrinogen, an increment of the fibrin degradation products (FDP), and bleeding tendency with the appearance of skin purpura. In each instance, the plasma thrombosis-inducing activity (TIA) appeared one to three days after chemotherapy and subsided subsequently. Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Platelet Count; Tegafur; Thrombosis; Vindesine	1992

Article

Year

Hypercoagulopathy induced by chemotherapy in a patient with lung cancer. A possible role for a factor with thrombosis-inducing activity (TIA).

Chest, 1992, Volume: 101, Issue:1

We treated a patient with lung cancer in whom a hypercoagulopathy was induced acutely by chemotherapy. He received systemic chemotherapy twice and in both instances developed disseminated intravascular coagulopathy (DIC), accompanied by acute decrements of the peripheral platelet count and plasma fibrinogen, an increment of the fibrin degradation products (FDP), and bleeding tendency with the appearance of skin purpura. In each instance, the plasma thrombosis-inducing activity (TIA) appeared one to three days after chemotherapy and subsided subsequently.

Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Platelet Count; Tegafur; Thrombosis; Vindesine

1992